Shani, O., Vorobyov, T., Monteran, L., Lavie, D., Cohen, N., Raz, Y., . . . Erez, N. (2020). Fibroblast-derived IL-33 facilitates breast cancer metastasis by modifying the immune microenvironment and driving type-2 immunity. Cancer Res.
Chicago ZitierstilShani, Ophir, et al. "Fibroblast-derived IL-33 Facilitates Breast Cancer Metastasis By Modifying the Immune Microenvironment and Driving Type-2 Immunity." Cancer Res 2020.
MLA ZitierstilShani, Ophir, et al. "Fibroblast-derived IL-33 Facilitates Breast Cancer Metastasis By Modifying the Immune Microenvironment and Driving Type-2 Immunity." Cancer Res 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.